Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Lilly sets up $50 million venture fund for medtech:

This article was originally published in Clinica

Executive Summary

A new venture capital fund targeting medical technology companies has been established by Eli Lilly. The Indianapolis, Indiana-based pharmaceutical group is seeking to invest $50m in placements of up to $5m. Its focus is a broad one: companies developing emerging and innovative technologies in the fields of diagnostics and therapeutic devices, as well as products combining pharmaceuticals, medical devices and/or diagnostics. Although Lilly has expertise in drug delivery, it is no longer the medtech heavyweight it once was. In the mid-1990s it decided to focus on pharmaceuticals, setting up Guidant to accommodate its medical device activities and divesting other non-pharma assets separately.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT057057

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel